BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34390620)

  • 21. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
    Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
    Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984.
    Osterlind A; Berthelsen JG; Abildgaard N; Hansen SO; Hjalgrim H; Johansen B; Munck-Hansen J; Rasmussen LH
    J Natl Cancer Inst; 1991 Oct; 83(19):1391-5. PubMed ID: 1656057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of small testicular masses: outcomes from a single-centre specialist multidisciplinary team.
    Wardak S; Pang KH; Castiglione F; Lindsay J; Walkden M; Ho DH; Kirkham A; Hadway P; Nigam R; Rees R; Alifrangis C; Alnajjar HM; Muneer A
    BJU Int; 2023 Jan; 131(1):73-81. PubMed ID: 35986901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of bilateral testicular germ cell cancer in Denmark, 1960-84: preliminary findings.
    Osterlind A; Berthelsen JG; Abildgaard N; Hansen SO; Jensen H; Johansen B; Munck-Hansen J; Rasmussen LH
    Int J Androl; 1987 Feb; 10(1):203-8. PubMed ID: 3034792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of testicular cancer after vasectomy: cohort study of over 73,000 men.
    Møller H; Knudsen LB; Lynge E
    BMJ; 1994 Jul; 309(6950):295-9. PubMed ID: 8086866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individual Treatment Progress Predicts Satisfaction With Transition-Related Care for Youth With Gender Dysphoria: A Prospective Clinical Cohort Study.
    Nieder TO; Mayer TK; Hinz S; Fahrenkrug S; Herrmann L; Becker-Hebly I
    J Sex Med; 2021 Mar; 18(3):632-645. PubMed ID: 33642235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testicular cancer at Kenyatta National Hospital, Nairobi.
    Opot EN; Magoha GA
    East Afr Med J; 2000 Feb; 77(2):80-5. PubMed ID: 10774080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence.
    Defreyne J; Vantomme B; Van Caenegem E; Wierckx K; De Blok CJM; Klaver M; Nota NM; Van Dijk D; Wiepjes CM; Den Heijer M; T'Sjoen G
    Andrology; 2018 May; 6(3):446-454. PubMed ID: 29602229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel rapid access testicular cancer clinic: prospective evaluation after one year.
    Carey K; Davis NF; Elamin S; Ahern P; Brady CM; Sweeney P
    Ir J Med Sci; 2016 Feb; 185(1):215-8. PubMed ID: 25772124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forensic alcohol calculations in transgender individuals undergoing gender-affirming hormonal treatment.
    Maskell PD; Sang KJC; Heymsfield SB; Shapses S; Dekorompay A
    J Forensic Sci; 2022 Jul; 67(4):1624-1631. PubMed ID: 35506759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
    Schaapveld M; van den Belt-Dusebout AW; Gietema JA; de Wit R; Horenblas S; Witjes JA; Hoekstra HJ; Kiemeney LA; Louwman WJ; Ouwens GM; Aleman BM; van Leeuwen FE
    Br J Cancer; 2012 Oct; 107(9):1637-43. PubMed ID: 23059747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germ-cell testicular cancer in offspring of Finnish immigrants to Sweden.
    Montgomery SM; Granath F; Ehlin A; Sparén P; Ekbom A
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):280-2. PubMed ID: 15668509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
    Géczi L; Gomez F; Bak M; Bodrogi I
    J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of cancer in relatives of testicular cancer patients.
    Heimdal K; Olsson H; Tretli S; Flodgren P; Børresen AL; Fossa SD
    Br J Cancer; 1996 Apr; 73(7):970-3. PubMed ID: 8611417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
    Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
    J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Gender Dysphoria in Southern Brazil: A Retrospective Study.
    Silva DC; Salati LR; Fontanari AMV; Schwarz K; Schneider MA; Soll BBM; Costa AB; Guadagnin F; Hirakata VN; Lobato MIR
    Arch Sex Behav; 2021 Nov; 50(8):3517-3526. PubMed ID: 34697689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study.
    Kier MGG; Lauritsen J; Almstrup K; Mortensen MS; Toft BG; Rajpert-De Meyts E; Skakkebaek NE; Rørth M; von der Maase H; Agerbaek M; Holm NV; Andersen KK; Dalton SO; Johansen C; Daugaard G
    Ann Oncol; 2015 Apr; 26(4):737-742. PubMed ID: 25542924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Explorative Prospective Evaluation of Short-Term Subjective Effects of Hormonal Treatment in Trans People-Results from the European Network for the Investigation of Gender Incongruence.
    van Dijk D; Dekker MJHJ; Conemans EB; Wiepjes CM; de Goeij EGM; Overbeek KA; Fisher AD; den Heijer M; T'Sjoen G
    J Sex Med; 2019 Aug; 16(8):1297-1309. PubMed ID: 31230940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment.
    de Blok CJM; Dijkman BAM; Wiepjes CM; Staphorsius AS; Timmermans FW; Smit JM; Dreijerink KMA; den Heijer M
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e782-e790. PubMed ID: 33206172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the most anticipated change induced by treatment using gender-affirming hormones in individuals with gender incongruence?
    Masumori N; Baba T; Abe T; Niwa K
    Int J Urol; 2021 May; 28(5):526-529. PubMed ID: 33465834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.